Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Harvard Business School
McKesson
Johnson and Johnson
Cantor Fitzgerald
Dow
Citi
Farmers Insurance

Generated: February 21, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for FARXIGA

« Back to Dashboard

Payment Methods and Pharmacy Types for FARXIGA (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $15,600,359
INSIDE ANOTHER STORE $240,349,038
[disabled in preview] $215,316,739
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 13,080
INSIDE ANOTHER STORE 550,841
[disabled in preview] 488,890
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $21,708,874
MEDICARE $69,778,034
[disabled in preview] $381,546,632
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for FARXIGA
Drug Units Sold Trends for FARXIGA

Annual Sales Revenues and Units Sold for FARXIGA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
FARXIGA ➤ Sign Up ➤ Sign Up 2016
FARXIGA ➤ Sign Up ➤ Sign Up 2015
FARXIGA ➤ Sign Up ➤ Sign Up 2014
FARXIGA ➤ Sign Up ➤ Sign Up 2013
FARXIGA ➤ Sign Up ➤ Sign Up 2012
FARXIGA ➤ Sign Up ➤ Sign Up 2011
FARXIGA ➤ Sign Up ➤ Sign Up 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Merck
Medtronic
Mallinckrodt
Baxter
Harvard Business School
QuintilesIMS
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.